U.S. Medical Weight Loss Clinics Market Size, Growth, Trends, Report 2023-2032
The U.S. medical weight loss clinics market was valued at USD 1.12 billion in 2022 and it is predicted to surpass around USD 1.71 billion by 2032 with a CAGR of 4.31% from 2023 to 2032.
Key Pointers
Report Scope of the U.S. Medical Weight Loss Clinics Market
| Report Coverage | Details |
| Market Size in 2022 | USD 1.12 billion |
| Revenue Forecast by 2032 | USD 1.71 billion |
| Growth rate from 2023 to 2032 | CAGR of 4.31% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Companies Covered | Cleveland Clinic (Obesity and Medical Weight Loss Center); Medical Weight Loss Clinic; Rivas Weight Loss; Medi IP, LLC (Medi-Weightloss); NYU Langone Hospitals; Stanford Health Care; UCLA Health; Long Island Weight Loss Institute; Cedars-Sinai; Allegheny Health Network; Options Medical Weight Loss; Med-Fit Medical Weight Loss |
The increasing prevalence of obesity in the adult U.S. population is expected to drive the growth of the market. According to the CDC statistics of 2022, around 20.7% of people aged 18 to 24 years have reported suffering from obesity, and around 39.3% of adults aged 45 to 54 years of age reported suffering from obesity in the U.S. Obesity is the second leading cause of mortality in the U.S. Obese people have higher risks for heart conditions, diabetes, high blood pressures, and others major health conditions.
Furthermore, patients are shifting from surgical weight loss methods towards non-surgical weight loss methods, owing to similar efficiency and results of the procedures. According to the American Society for Metabolic and Bariatric Surgery, estimated 198,651 bariatric surgeries were performed in 2020 in the U.S., a decline from 256,000 surgeries performed in 2019. The shift of patients can be attributed to the higher cost associated with bariatric surgeries and the risk associated with surgical procedures. According to the American Society for Metabolic and Bariatric Surgery, the average cost of bariatric surgery in the U.S. is around USD 17,000 to USD 26,000. This is much higher compared to medical weight loss programs.
Moreover, with several weight loss medications launched in the U.S., the demand for medical weight loss treatments is constantly rising. For instance, in June 2021, the U.S. FDA approved Wegovy (semaglutide) for chronic weight management in adults. The drug is intended to be used in combination with exercise and a healthy diet and reported 15% to 18% weight loss findings during the clinical trials of the product. Moreover, in May 2023, the Eli Lilly Company announced to seek U.S. FDA approval for Trizepatide for weight loss in the U.S. The drug is approved for type-2 diabetes and has reported positive weight loss effects in clinical trials.
The U.S. weight loss clinic industry was negatively impacted by the COVID-19 pandemic in the early phase due to the closure of the programs to maintain social distancing to curb the spread of the virus. According to the study published in the MedScape on VHA MOVE Weight Management Program during and before the pandemic, the monthly participation in the program in April and May 2020 was around 50% to 60% lower compared to the same period in 2019. However, participation started to increase in the latter months of 2020 and reached pre-pandemic levels in 2021. This can be attributed to the shift of patients from in-person programs to telehealth programs.
Ownership Insights
Based on the ownership, the market is categorized into hospital-based and standalone clinics. The standalone segment dominated with a revenue share of 61% in 2022. This can be attributed to the presence of a large number of clinics at different locations and the presence of specialized staff in the centers. Moreover, the increased patient burden on hospitals during the pandemic has shifted patients from hospital-based settings toward standalone facilities.
These clinics offer personalized programs at a discounted rate and are available at many locations. For instance, Medi IP, LLC has a presence in more than 103 locations in the U.S. and serves more than 300,000 patients in the U.S. Market players are opening new clinics at different locations to increase their market presence. For instance, in August 2022, Modern Medical Weight Loss opened a new medical weight loss clinic in Kentucky offering advanced medical weight loss solutions.
The hospital-based segment is expected to witness the fastest growth over the forecast period. This can be attributed to the availability of advanced technologies and well-established physician networks across the U.S. Many major hospitals are offering medical weight loss programs in the U.S., including Cleveland Clinic, John Hopkins Health System, Cedar-Sinai, and many others.
U.S. Medical Weight Loss Clinics Market Segmentations:
By Ownership
Chapter 1. Introduction
1.1.Research Objective
1.2.Scope of the Study
1.3.Definition
Chapter 2. Research Methodology
2.1.Research Approach
2.2.Data Sources
2.3.Assumptions & Limitations
Chapter 3. Executive Summary
3.1.Market Snapshot
Chapter 4. Market Variables and Scope
4.1.Introduction
4.2.Market Classification and Scope
4.3.Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5.COVID 19 Impact on U.S. Medical Weight Loss Clinics Market
5.1. COVID-19 Landscape: U.S. Medical Weight Loss Clinics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4.Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1.Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2.Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1.List of Suppliers
7.1.3.2.List of Buyers
Chapter 8. U.S. Medical Weight Loss Clinics Market, By Ownership
8.1.U.S. Medical Weight Loss Clinics Market, by Ownership Type, 2023-2032
8.1.1. Hospital-based
8.1.1.1.Market Revenue and Forecast (2020-2032)
8.1.2. Standalone
8.1.2.1.Market Revenue and Forecast (2020-2032)
Chapter 9. U.S. Medical Weight Loss Clinics Market, Regional Estimates and Trend Forecast
9.1. U.S.
9.1.1. Market Revenue and Forecast, by Ownership (2020-2032)
Chapter 10.Company Profiles
10.1. Cleveland Clinic (Obesity and Medical Weight Loss Center)
10.1.1.Company Overview
10.1.2.Product Offerings
10.1.3.Financial Performance
10.1.4.Recent Initiatives
10.2. Medical Weight Loss Clinic
10.2.1.Company Overview
10.2.2.Product Offerings
10.2.3.Financial Performance
10.2.4.Recent Initiatives
10.3. Rivas Weight Loss
10.3.1.Company Overview
10.3.2.Product Offerings
10.3.3.Financial Performance
10.3.4.Recent Initiatives
10.4. Medi IP, LLC (Medi-Weightloss)
10.4.1.Company Overview
10.4.2.Product Offerings
10.4.3.Financial Performance
10.4.4.Recent Initiatives
10.5. NYU Langone Hospitals
10.5.1.Company Overview
10.5.2.Product Offerings
10.5.3.Financial Performance
10.5.4.Recent Initiatives
10.6. Stanford Health Care
10.6.1.Company Overview
10.6.2.Product Offerings
10.6.3.Financial Performance
10.6.4.Recent Initiatives
10.7. UCLA Health
10.7.1.Company Overview
10.7.2.Product Offerings
10.7.3.Financial Performance
10.7.4.Recent Initiatives
10.8. Long Island Weight Loss Institute
10.8.1.Company Overview
10.8.2.Product Offerings
10.8.3.Financial Performance
10.8.4.Recent Initiatives
10.9. Cedars-Sinai
10.9.1.Company Overview
10.9.2.Product Offerings
10.9.3.Financial Performance
10.9.4.Recent Initiatives
10.10. Allegheny Health Network
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11.Research Methodology
11.1.Primary Research
11.2.Secondary Research
11.3.Assumptions
Chapter 12.Appendix
12.1. About Us
12.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers